News
News

The latest updates from AFAR.

Board member in the News: Nir Barzilai in The Times UK on Metformin and TAME

May 21
2019

Board member in the News: Nir Barzilai in The Times UK on Metformin and TAME

  On May 18, 2019, The Times UK featured AFAR expert Nir Barzilai, MD in an article on the Targeting Aging with Metformin (TAME) Trial, which AFAR is helping manage. Dr. Barzilai is AFAR’s Deputy Scientific Director, 2010 Irving S. Wright Award winner, and a multiple grantee. Read the article—“Is Metformin the key to living longer?”—here.  


View MoreREAD MORE


Board member in the News: Mark Lachs on Age-Associated Financial Vulnerability on NPR Marketplace

May 21
2019

Board member in the News: Mark Lachs on Age-Associated Financial Vulnerability on NPR Marketplace

  On May 16, 2019, NPR Marketplace featured AFAR expert Mark S. Lachs, MD, MPH in an article on cognitive changes and “age-associated financial vulnerability.” Dr. Lachs is AFAR’s Board President and a 1995 Beeson scholar. Read the article—"Age of fraud: Are seniors more vulnerable to financial scams?”—here. If you are in the NYC area, tune into WNYC on Thursday May 23 at 8pm to hear Dr. Lachs in a related segment. The article coincides with the launch of a new initiative and website, ElderAbuse.org For more on cognitive changes and the risk…


View MoreREAD MORE


Grantees in the News: Kenneth Langa and Donovan Maust on National Poll on Healthy Aging Report: Thinking about Brain Health, in Medical Express

May 21
2019

Grantees in the News: Kenneth Langa and Donovan Maust on National Poll on Healthy Aging Report: Thinking about Brain Health, in Medical Express

  On May 15, 2019, MedicalExpress featured insights from AFAR experts Kenneth Langa, MD, PhD and Donovan T. Maust, MD in article highlighting findings from the recently published National Poll on Healthy Aging Report: Thinking About Brain Health, which Dr. Maust organized. In all, nearly half of respondents to the National Poll on Healthy Aging felt they were likely to develop dementia as they aged, and nearly as many worried about this prospect. In reality, research suggests that less than 20 percent of people who have reached age 65 will go on to lose cognitive ability from Alzheimer's disease, vascular dementia or…


View MoreREAD MORE


Board member in the News: STAT News spotlights Ned David and Unity Biotech

May 21
2019

Board member in the News: STAT News spotlights Ned David and Unity Biotech

On May 14, 2019, STAT News spotlighted AFAR expert Nathanial “Ned” David, PhD in a feature on his leadership to advance therapeutics to target aging through Unity Biotech. Dr. David is an AFAR Board member. He also received AFAR's Honorary Leadership Award of Distinction in 2017. Read “How a biotech executive seizes on big ideas, from anti-aging therapies to antibiotics” here.  


View MoreREAD MORE


Grantee in the News: Dena Dubal in Scientic American on VCAM1 protein and preventing cognitive decline

May 20
2019

Grantee in the News: Dena Dubal in Scientic American on VCAM1 protein and preventing cognitive decline

  On May 14, 2019, Scientific American featured insights by AFAR expert Dena Dubal, MD, PhD in an article exploring how in mice studies, blocking the VCAM1 protein may reverse in brain decline and prevent memory loss. Dr. Dubal is a 2015 AFAR Research Grant for Junior Faculty recipient, 2009 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, and 1998 Glenn/AFAR Scholarships for Research in the Biology of Aging recipient. Dr. Dubal also served on the 2018 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty Selection Committee. Read the article—“Thwarting a Protein Reverses Brain Decline in…


View MoreREAD MORE




BACK TO TOPBACK TO TOP